10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14,514 | -3,636 | -112,485 | -18,762 |
| Depreciation Amortization | 2,180 | 1,036 | 3,905 | 4,305 |
| Accounts receivable | 1,360 | 2,674 | N/A | N/A |
| Accounts payable and accrued liabilities | -986 | -1,269 | N/A | N/A |
| Other Working Capital | 20,691 | 9,979 | 28,015 | 1,948 |
| Other Operating Activity | 4,670 | 534 | 4,156 | 1,810 |
| Operating Cash Flow | $13,401 | $9,318 | $-76,409 | $-10,699 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -22,508 | -9,367 | -6,284 | -3,756 |
| Other Investing Activity | 0 | 0 | -425 | 0 |
| Investing Cash Flow | $-22,508 | $-9,367 | $-6,709 | $-3,756 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 2,005 | 923 | N/A | N/A |
| Other Financing Activity | -1,946 | 0 | 105,367 | 20,583 |
| Financing Cash Flow | $59 | $923 | $105,367 | $20,583 |
| Exchange Rate Effect | 2 | -2 | -18 | -14 |
| Beginning Cash Position | 70,088 | 70,088 | 47,857 | 41,743 |
| End Cash Position | 61,042 | 70,960 | 70,088 | 47,857 |
| Net Cash Flow | $-9,046 | $872 | $22,231 | $6,114 |
| Free Cash Flow | ||||
| Operating Cash Flow | 13,401 | 9,318 | -76,409 | -10,699 |
| Capital Expenditure | -22,508 | -9,367 | N/A | N/A |
| Free Cash Flow | -9,107 | -49 | -76,409 | -10,699 |